-
1
-
-
0034608753
-
2 receptors by dopamine in schizophrenia
-
2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. 97 (2000) 8104-8109
-
(2000)
Proc. Natl. Acad. Sci.
, vol.97
, pp. 8104-8109
-
-
Abi-Dargham, A.1
Rodenhiser, J.2
Printz, D.3
Zea-ponce, Y.4
Gil, R.5
Kegeles, L.S.6
Weiss, R.7
Cooper, T.B.8
Mann, J.J.9
Van Heertum, R.L.10
Gorman, J.M.11
Laruelle, M.12
-
2
-
-
67349207461
-
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects
-
Abi-Dargham A., van de Giessen E., Slifstein M., Kegeles L.S., and Laruelle M. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects. Biol. Psychiatry 65 (2009) 1091-1093
-
(2009)
Biol. Psychiatry
, vol.65
, pp. 1091-1093
-
-
Abi-Dargham, A.1
van de Giessen, E.2
Slifstein, M.3
Kegeles, L.S.4
Laruelle, M.5
-
3
-
-
67349262381
-
Effects of the dopamine stabilizer, OSU-6162, on brain stimulation reward and on quinpirole-induced changes in reward and locomotion
-
Benaliouad F., Kapur S., Natesan S., and Rompré P.-P. Effects of the dopamine stabilizer, OSU-6162, on brain stimulation reward and on quinpirole-induced changes in reward and locomotion. Eur. Neuropsychopharmacol. 19 (2009) 416-430
-
(2009)
Eur. Neuropsychopharmacol.
, vol.19
, pp. 416-430
-
-
Benaliouad, F.1
Kapur, S.2
Natesan, S.3
Rompré, P.-P.4
-
4
-
-
29244459436
-
The substituted (S)-3-phenylpiperidine (-)-OSU6162 reduces apomorphine- and amphetamine-induced behavior in Cebus paella monkeys
-
Brandt-Christensen M., Andersen M.B., Fink-Jensen A., Werge T., and Gerlach J. The substituted (S)-3-phenylpiperidine (-)-OSU6162 reduces apomorphine- and amphetamine-induced behavior in Cebus paella monkeys. J. Neural Transm. 113 (2006) 11-19
-
(2006)
J. Neural Transm.
, vol.113
, pp. 11-19
-
-
Brandt-Christensen, M.1
Andersen, M.B.2
Fink-Jensen, A.3
Werge, T.4
Gerlach, J.5
-
5
-
-
0036089687
-
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
-
Burris K.D., Molski T.F., Xu C., Ryan E., Tottori K., Kikuchi T., Yocca F.D., and Molinoff P.B. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J. Pharmacol. Exp. Ther. 302 (2002) 381-389
-
(2002)
J. Pharmacol. Exp. Ther.
, vol.302
, pp. 381-389
-
-
Burris, K.D.1
Molski, T.F.2
Xu, C.3
Ryan, E.4
Tottori, K.5
Kikuchi, T.6
Yocca, F.D.7
Molinoff, P.B.8
-
6
-
-
33646152528
-
A dopaminergic deficit hypothesis of scizophrenia: the path to discovery
-
Carlsson A., and Carlsson M.L. A dopaminergic deficit hypothesis of scizophrenia: the path to discovery. Dialogues Clin. Neurosci. 8 (2006) 137-142
-
(2006)
Dialogues Clin. Neurosci.
, vol.8
, pp. 137-142
-
-
Carlsson, A.1
Carlsson, M.L.2
-
7
-
-
1242329383
-
Schizophrenia: from dopamine to glutamate and back
-
Carlsson M.L., Carlsson A., and Nilsson M. Schizophrenia: from dopamine to glutamate and back. Curr. Med. Chem. 11 (2004) 267-277
-
(2004)
Curr. Med. Chem.
, vol.11
, pp. 267-277
-
-
Carlsson, M.L.1
Carlsson, A.2
Nilsson, M.3
-
10
-
-
0017255979
-
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
-
Creese I., Burt D.R., and Snyder S.H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192 (1976) 481-483
-
(1976)
Science
, vol.192
, pp. 481-483
-
-
Creese, I.1
Burt, D.R.2
Snyder, S.H.3
-
11
-
-
0034681363
-
Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions
-
Ekesbo A., Andrén P.E., Gunne L.M., Sonesson C., and Tedroff J. Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions. Eur. J. Pharmacol. 389 (2000) 193-199
-
(2000)
Eur. J. Pharmacol.
, vol.389
, pp. 193-199
-
-
Ekesbo, A.1
Andrén, P.E.2
Gunne, L.M.3
Sonesson, C.4
Tedroff, J.5
-
12
-
-
0023853769
-
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs
-
Farde L., Wiesel F.A., Halldin C., and Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiatry 45 (1988) 71-76
-
(1988)
Arch. Gen. Psychiatry
, vol.45
, pp. 71-76
-
-
Farde, L.1
Wiesel, F.A.2
Halldin, C.3
Sedvall, G.4
-
13
-
-
0035801722
-
1A-receptor affinities
-
1A-receptor affinities. Bioorg. Med. Chem. Lett. 11 (2001) 2345-2349
-
(2001)
Bioorg. Med. Chem. Lett.
, vol.11
, pp. 2345-2349
-
-
Feenstra, R.W.1
de Moes, J.2
Hofma, J.J.3
Kling, H.4
Kuipers, W.5
Long, S.K.6
Tulp, M.T.M.7
van der Hayden, J.A.M.8
Kruse, C.G.9
-
14
-
-
51149108773
-
Prolactin and dopamine: What is the connection?
-
Fitzgerald P., and Dinan T.G. Prolactin and dopamine: What is the connection?. J. Psychopharmacol. 22 (2008) 12-19
-
(2008)
J. Psychopharmacol.
, vol.22
, pp. 12-19
-
-
Fitzgerald, P.1
Dinan, T.G.2
-
16
-
-
33750473056
-
2 receptor partial agonist
-
2 receptor partial agonist. Eur. J. Pharmacol. 552 (2006) 36-45
-
(2006)
Eur. J. Pharmacol.
, vol.552
, pp. 36-45
-
-
Heinrich, J.N.1
Brennan, J.2
Lai, M.H.3
Sullivan, K.4
Hornby, G.5
Popiolek, M.6
Jiang, L.-X.7
Pausch, M.H.8
Stack, G.9
Marquis, K.L.10
Andree, T.H.11
-
18
-
-
0035660215
-
2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient
-
2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol. Psychiatry 50 (2001) 873-883
-
(2001)
Biol. Psychiatry
, vol.50
, pp. 873-883
-
-
Kapur, S.1
Remington, G.2
-
19
-
-
0034109940
-
2 receptors. Implications for atypical antipsychotic action
-
2 receptors. Implications for atypical antipsychotic action. J. Psychiatry Neurosci. 25 (2000) 161-166
-
(2000)
J. Psychiatry Neurosci.
, vol.25
, pp. 161-166
-
-
Kapur, S.1
Seeman, P.2
-
20
-
-
0035094264
-
2 receptor explain the action of atypical antipsychotics?: A new hypothesis
-
2 receptor explain the action of atypical antipsychotics?: A new hypothesis. Am. J. Psychiatry 158 (2001) 360-369
-
(2001)
Am. J. Psychiatry
, vol.158
, pp. 360-369
-
-
Kapur, S.1
Seeman, P.2
-
21
-
-
0034025771
-
2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia
-
2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am. J. Psychiatry 157 (2000) 514-520
-
(2000)
Am. J. Psychiatry
, vol.157
, pp. 514-520
-
-
Kapur, S.1
Zipursky, R.2
Jones, C.3
Remington, G.4
Houle, S.5
-
22
-
-
0037035393
-
2 affinity results in the loss of clozapine's atypical antipsychotic action
-
2 affinity results in the loss of clozapine's atypical antipsychotic action. NeuroReport 13 (2002) 831-835
-
(2002)
NeuroReport
, vol.13
, pp. 831-835
-
-
Kapur, S.1
McClelland, R.A.2
VanderSpek, S.C.3
Wadenberg, M.-L.G.4
Baker, G.5
Nobrega, J.6
Zipursky, R.B.7
Seeman, P.8
-
24
-
-
3242686015
-
qo5
-
qo5. Biochem. Pharmacol. 68 (2004) 761-772
-
(2004)
Biochem. Pharmacol.
, vol.68
, pp. 761-772
-
-
Moreland, R.B.1
Nakane, M.2
Donnelly-Roberts, D.L.3
Miller, L.N.4
Chang, R.5
Uchic, M.E.6
Terranova, M.A.7
Gubbins, E.J.8
Hekfrich, R.J.9
Namovic, M.T.10
El-Kouhen, O.F.11
Masters, J.N.12
Brioni, J.D.13
-
25
-
-
33745933839
-
2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat
-
2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat. J. Pharmacol. Exp. Ther. 318 (2006) 810-818
-
(2006)
J. Pharmacol. Exp. Ther.
, vol.318
, pp. 810-818
-
-
Natesan, S.1
Svensson, K.A.2
Reckless, G.E.3
Nobrega, J.N.4
Barlow, K.B.L.5
Johansson, A.M.6
Kapur, S.7
-
26
-
-
0036801619
-
PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's Disease
-
Nichols N.F., Cimini M.G., Hass J.V., Staton B.A., Tedroff J., and Svensson K.A. PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's Disease. Neuropharmacology 43 (2002) 817-824
-
(2002)
Neuropharmacology
, vol.43
, pp. 817-824
-
-
Nichols, N.F.1
Cimini, M.G.2
Hass, J.V.3
Staton, B.A.4
Tedroff, J.5
Svensson, K.A.6
-
27
-
-
3342939299
-
The dopaminergic stabilizer ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition
-
Nilsson M., Carlsson A., Markinhuhta K.R., Sonesson C., Pettersson F., Gullme M., and Carlsson M.L. The dopaminergic stabilizer ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 677-685
-
(2004)
Prog. Neuropsychopharmacol. Biol. Psychiatry
, vol.28
, pp. 677-685
-
-
Nilsson, M.1
Carlsson, A.2
Markinhuhta, K.R.3
Sonesson, C.4
Pettersson, F.5
Gullme, M.6
Carlsson, M.L.7
-
28
-
-
38149001461
-
Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats
-
Nordquist R.E., Risterucci C., Moreau J.L., von Kienlin M., Künnecke B., Maco M., Freichel C., Riemer C., and Spooren W. Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats. Neuropharmacology 54 (2008) 405-416
-
(2008)
Neuropharmacology
, vol.54
, pp. 405-416
-
-
Nordquist, R.E.1
Risterucci, C.2
Moreau, J.L.3
von Kienlin, M.4
Künnecke, B.5
Maco, M.6
Freichel, C.7
Riemer, C.8
Spooren, W.9
-
30
-
-
44949208426
-
Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization
-
Rung J.P., Rung E., Helgeson L., Johansson A.M., Svensson K., Carlsson A., and Carlsson M.L. Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization. J. Neural Transm. 115 (2008) 899-908
-
(2008)
J. Neural Transm.
, vol.115
, pp. 899-908
-
-
Rung, J.P.1
Rung, E.2
Helgeson, L.3
Johansson, A.M.4
Svensson, K.5
Carlsson, A.6
Carlsson, M.L.7
-
31
-
-
0029930927
-
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
-
Schotte A., Janssen P.F.M., Gommeren W., Luyten W.H.M.L., Van Gompel P., Lesage A.S., De Loore K., and Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124 (1996) 57-73
-
(1996)
Psychopharmacology
, vol.124
, pp. 57-73
-
-
Schotte, A.1
Janssen, P.F.M.2
Gommeren, W.3
Luyten, W.H.M.L.4
Van Gompel, P.5
Lesage, A.S.6
De Loore, K.7
Leysen, J.E.8
-
32
-
-
34547659151
-
Multiple dopamine functions at different time courses
-
Schultz W. Multiple dopamine functions at different time courses. Annu. Rev. Neurosci. 30 (2007) 259-288
-
(2007)
Annu. Rev. Neurosci.
, vol.30
, pp. 259-288
-
-
Schultz, W.1
-
33
-
-
0036221550
-
Atypical antipsychotics: mechanism of action
-
Seeman P. Atypical antipsychotics: mechanism of action. Can. J. Psychiatry 47 (2002) 27-38
-
(2002)
Can. J. Psychiatry
, vol.47
, pp. 27-38
-
-
Seeman, P.1
-
34
-
-
33846702551
-
Dopamine partial agonist action of (-)OSU6162 is consistent with dopamine hyperactivity in psychosis
-
Seeman P., and Guan H.-C. Dopamine partial agonist action of (-)OSU6162 is consistent with dopamine hyperactivity in psychosis. Eur. J. Pharmacol. 557 (2007) 151-153
-
(2007)
Eur. J. Pharmacol.
, vol.557
, pp. 151-153
-
-
Seeman, P.1
Guan, H.-C.2
-
35
-
-
0032973806
-
2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine
-
2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am. J. Psychiatry 156 (1999) 876-884
-
(1999)
Am. J. Psychiatry
, vol.156
, pp. 876-884
-
-
Seeman, P.1
Tallerico, T.2
-
36
-
-
0017068246
-
Antipsychotic drug doses and neuroleptic/dopamine receptors
-
Seeman P., Lee T., Chau-Wong M., and Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261 (1976) 717-719
-
(1976)
Nature
, vol.261
, pp. 717-719
-
-
Seeman, P.1
Lee, T.2
Chau-Wong, M.3
Wong, K.4
-
37
-
-
0043269348
-
3H]spiperone in isotonic medium: implications for human positron emission tomography
-
3H]spiperone in isotonic medium: implications for human positron emission tomography. Synapse 49 (2003) 209-215
-
(2003)
Synapse
, vol.49
, pp. 209-215
-
-
Seeman, P.1
Tallerico, T.2
Ko, F.3
-
39
-
-
0028135190
-
An efficient synthesis of the novel dopamine autoreceptor antagonist S-(-)-OSU6162, via palladium catalyzed cross-coupling reaction
-
Sonesson C., and Lindborg J. An efficient synthesis of the novel dopamine autoreceptor antagonist S-(-)-OSU6162, via palladium catalyzed cross-coupling reaction. Tetrahedron Lett. 35 (1994) 9063-9066
-
(1994)
Tetrahedron Lett.
, vol.35
, pp. 9063-9066
-
-
Sonesson, C.1
Lindborg, J.2
-
40
-
-
0027934781
-
Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure- activity relationships
-
Sonesson C., Lin C.-H., Hansson L., Waters N., Svensson K., Carlsson A., Smith M.W., and Wikström H. Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure- activity relationships. J. Med. Chem. 37 (1994) 2735-2753
-
(1994)
J. Med. Chem.
, vol.37
, pp. 2735-2753
-
-
Sonesson, C.1
Lin, C.-H.2
Hansson, L.3
Waters, N.4
Svensson, K.5
Carlsson, A.6
Smith, M.W.7
Wikström, H.8
-
41
-
-
35348854954
-
Differences in agonist/antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ 208-912
-
Tadori Y., Kitagawa H., Forbes R.A., McQuade R.D., Stark A., and Kikuchi T. Differences in agonist/antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ 208-912. Eur. J. Pharmacol. 574 (2007) 103-111
-
(2007)
Eur. J. Pharmacol.
, vol.574
, pp. 103-111
-
-
Tadori, Y.1
Kitagawa, H.2
Forbes, R.A.3
McQuade, R.D.4
Stark, A.5
Kikuchi, T.6
-
42
-
-
0031913840
-
Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity
-
Tedroff J., Torstenson R., Hartvig P., Sonesson C., Waters N., Carlsson A., Neu H., Fasth K.-J., and Långström B. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity. Synapse 28 (1998) 280-287
-
(1998)
Synapse
, vol.28
, pp. 280-287
-
-
Tedroff, J.1
Torstenson, R.2
Hartvig, P.3
Sonesson, C.4
Waters, N.5
Carlsson, A.6
Neu, H.7
Fasth, K.-J.8
Långström, B.9
-
43
-
-
0032693984
-
Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease
-
Tedroff J., Ekesbo A., Sonesson C., Waters N., and Carlsson A. Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease. Neurology 53 (1999) 1605-1606
-
(1999)
Neurology
, vol.53
, pp. 1605-1606
-
-
Tedroff, J.1
Ekesbo, A.2
Sonesson, C.3
Waters, N.4
Carlsson, A.5
|